搜尋結果
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of ...
CNBC· 3 小時前Eli Lilly on Friday said it applied for U.S. approval of its weight loss drug Zepbound for the ...
Ilya Sutskever's new AI venture, and time to BeReal about bankruptcy
TechCrunch· 6 小時前This week, co-hosts Mary Ann Azevedo and Haje Kamps are joined by the ever-insightful Kirsten ...
Weight loss drug contender Zealand Pharma jumps 18% on trial results
CNBC· 13 小時前One out of 48 study participants withdrew due to negative effects. Petrelintide was ...
Weight-Loss Drugs Dangers Explained: Zepbound, Mounjaro Maker Warn Of Coming Counterfeit Lawsuit
Forbes· 2 日前Several medical spas and wellness centers are facing potential lawsuits from drugmaker Eli ...
‘Diane von Furstenberg: Woman in Charge’ Review: Timeless Chic With a Dose of Cheek
The Wall Street Journal· 1 日前For many male viewers, including this one, “Diane von Furstenberg” is a fashion name you’ve ...
European shares open lower as tech losses weigh
Reuters· 15 小時前European shares opened lower on Friday, with technology shares at the helm of the selloff, ...
'Inside Out 2' hits $155 million domestic debut, second-highest animation opening ever
CNBC· 5 日前Disney and Pixar brought a big dose of joy to the box office this weekend. "Inside Out ...
Generative AI Offers A Sturdy Dose Of Emotional CPR With A Tad Of Mental Health First Aid
Forbes· 6 日前In today’s column, I am continuing my ongoing series about the impact of generative AI in the ...
Zealand Pharma Shares Jump 17% After Positive Trial Results For Ozempic Competitor
Forbes· 18 小時前One participant in the trial withdrew after they experienced nausea and vomiting after taking petrelintide, while no other ...
19 Brands To Wear This Summer For That Elevated Cool Look
Forbes· 2 日前Think minimalistic bodysuits, nostalgic halter necks, sheer layers and oversized outerwear, the ...